Characterization of α-Glucosidase Inhibitors from Clinacanthus nutans Lindau Leaves by Gas Chromatography-Mass Spectrometry-Based Metabolomics and Molecular Docking Simulation

Background: Clinacanthus nutans (C. nutans) is an Acanthaceae herbal shrub traditionally consumed to treat various diseases including diabetes in Malaysia. This study was designed to evaluate the α-glucosidase inhibitory activity of C. nutans leaves extracts, and to identify the metabolite...

Full description

Bibliographic Details
Main Authors: Suganya Murugesu, Zalikha Ibrahim, Qamar-Uddin Ahmed, Nik-Idris Nik Yusoff, Bisha-Fathamah Uzir, Vikneswari Perumal, Faridah Abas, Khozirah Saari, Hesham El-Seedi, Alfi Khatib
Format: Article
Language:English
Published: MDPI AG 2018-09-01
Series:Molecules
Subjects:
Online Access:http://www.mdpi.com/1420-3049/23/9/2402
_version_ 1828529183876186112
author Suganya Murugesu
Zalikha Ibrahim
Qamar-Uddin Ahmed
Nik-Idris Nik Yusoff
Bisha-Fathamah Uzir
Vikneswari Perumal
Faridah Abas
Khozirah Saari
Hesham El-Seedi
Alfi Khatib
author_facet Suganya Murugesu
Zalikha Ibrahim
Qamar-Uddin Ahmed
Nik-Idris Nik Yusoff
Bisha-Fathamah Uzir
Vikneswari Perumal
Faridah Abas
Khozirah Saari
Hesham El-Seedi
Alfi Khatib
author_sort Suganya Murugesu
collection DOAJ
description Background: Clinacanthus nutans (C. nutans) is an Acanthaceae herbal shrub traditionally consumed to treat various diseases including diabetes in Malaysia. This study was designed to evaluate the α-glucosidase inhibitory activity of C. nutans leaves extracts, and to identify the metabolites responsible for the bioactivity. Methods: Crude extract obtained from the dried leaves using 80% methanolic solution was further partitioned using different polarity solvents. The resultant extracts were investigated for their α-glucosidase inhibitory potential followed by metabolites profiling using the gas chromatography tandem with mass spectrometry (GC-MS). Results: Multivariate data analysis was developed by correlating the bioactivity, and GC-MS data generated a suitable partial least square (PLS) model resulting in 11 bioactive compounds, namely, palmitic acid, phytol, hexadecanoic acid (methyl ester), 1-monopalmitin, stigmast-5-ene, pentadecanoic acid, heptadecanoic acid, 1-linolenoylglycerol, glycerol monostearate, alpha-tocospiro B, and stigmasterol. In-silico study via molecular docking was carried out using the crystal structure Saccharomyces cerevisiae isomaltase (PDB code: 3A4A). Interactions between the inhibitors and the protein were predicted involving residues, namely LYS156, THR310, PRO312, LEU313, GLU411, and ASN415 with hydrogen bond, while PHE314 and ARG315 with hydrophobic bonding. Conclusion: The study provides informative data on the potential α-glucosidase inhibitors identified in C. nutans leaves, indicating the plant’s therapeutic effect to manage hyperglycemia.
first_indexed 2024-12-11T22:04:12Z
format Article
id doaj.art-c47f115e436340aabd2317aec65c51f1
institution Directory Open Access Journal
issn 1420-3049
language English
last_indexed 2024-12-11T22:04:12Z
publishDate 2018-09-01
publisher MDPI AG
record_format Article
series Molecules
spelling doaj.art-c47f115e436340aabd2317aec65c51f12022-12-22T00:49:00ZengMDPI AGMolecules1420-30492018-09-01239240210.3390/molecules23092402molecules23092402Characterization of α-Glucosidase Inhibitors from Clinacanthus nutans Lindau Leaves by Gas Chromatography-Mass Spectrometry-Based Metabolomics and Molecular Docking SimulationSuganya Murugesu0Zalikha Ibrahim1Qamar-Uddin Ahmed2Nik-Idris Nik Yusoff3Bisha-Fathamah Uzir4Vikneswari Perumal5Faridah Abas6Khozirah Saari7Hesham El-Seedi8Alfi Khatib9Department of Pharmaceutical Chemistry, Kulliyyah of Pharmacy, International Islamic University Malaysia, Kuantan 25200, Pahang Darul Makmur, MalaysiaDepartment of Pharmaceutical Chemistry, Kulliyyah of Pharmacy, International Islamic University Malaysia, Kuantan 25200, Pahang Darul Makmur, MalaysiaDepartment of Pharmaceutical Chemistry, Kulliyyah of Pharmacy, International Islamic University Malaysia, Kuantan 25200, Pahang Darul Makmur, MalaysiaDepartment of Pharmaceutical Chemistry, Kulliyyah of Pharmacy, International Islamic University Malaysia, Kuantan 25200, Pahang Darul Makmur, MalaysiaDepartment of Pharmaceutical Chemistry, Kulliyyah of Pharmacy, International Islamic University Malaysia, Kuantan 25200, Pahang Darul Makmur, MalaysiaFaculty Pharmacy & Health Sciences, Universiti Kuala Lumpur Royal College of Medicine Perak, Ipoh 30450, Perak Darul Ridzuan, MalaysiaLaboratory of Natural Products, Institute of Bioscience, Universiti Putra Malaysia, Serdang 43300, Selangor Darul Ehsan, MalaysiaLaboratory of Natural Products, Institute of Bioscience, Universiti Putra Malaysia, Serdang 43300, Selangor Darul Ehsan, MalaysiaDivision of Pharmacognosy, Department of Medicinal Chemistry, Biomedical Centre, Uppsala University, Box 574, SE-751 23 Uppsala, SwedenDepartment of Pharmaceutical Chemistry, Kulliyyah of Pharmacy, International Islamic University Malaysia, Kuantan 25200, Pahang Darul Makmur, MalaysiaBackground: Clinacanthus nutans (C. nutans) is an Acanthaceae herbal shrub traditionally consumed to treat various diseases including diabetes in Malaysia. This study was designed to evaluate the α-glucosidase inhibitory activity of C. nutans leaves extracts, and to identify the metabolites responsible for the bioactivity. Methods: Crude extract obtained from the dried leaves using 80% methanolic solution was further partitioned using different polarity solvents. The resultant extracts were investigated for their α-glucosidase inhibitory potential followed by metabolites profiling using the gas chromatography tandem with mass spectrometry (GC-MS). Results: Multivariate data analysis was developed by correlating the bioactivity, and GC-MS data generated a suitable partial least square (PLS) model resulting in 11 bioactive compounds, namely, palmitic acid, phytol, hexadecanoic acid (methyl ester), 1-monopalmitin, stigmast-5-ene, pentadecanoic acid, heptadecanoic acid, 1-linolenoylglycerol, glycerol monostearate, alpha-tocospiro B, and stigmasterol. In-silico study via molecular docking was carried out using the crystal structure Saccharomyces cerevisiae isomaltase (PDB code: 3A4A). Interactions between the inhibitors and the protein were predicted involving residues, namely LYS156, THR310, PRO312, LEU313, GLU411, and ASN415 with hydrogen bond, while PHE314 and ARG315 with hydrophobic bonding. Conclusion: The study provides informative data on the potential α-glucosidase inhibitors identified in C. nutans leaves, indicating the plant’s therapeutic effect to manage hyperglycemia.http://www.mdpi.com/1420-3049/23/9/2402α-glucosidase inhibitorsClinacanthus nutansdiabetesGC-MSpartial least square
spellingShingle Suganya Murugesu
Zalikha Ibrahim
Qamar-Uddin Ahmed
Nik-Idris Nik Yusoff
Bisha-Fathamah Uzir
Vikneswari Perumal
Faridah Abas
Khozirah Saari
Hesham El-Seedi
Alfi Khatib
Characterization of α-Glucosidase Inhibitors from Clinacanthus nutans Lindau Leaves by Gas Chromatography-Mass Spectrometry-Based Metabolomics and Molecular Docking Simulation
Molecules
α-glucosidase inhibitors
Clinacanthus nutans
diabetes
GC-MS
partial least square
title Characterization of α-Glucosidase Inhibitors from Clinacanthus nutans Lindau Leaves by Gas Chromatography-Mass Spectrometry-Based Metabolomics and Molecular Docking Simulation
title_full Characterization of α-Glucosidase Inhibitors from Clinacanthus nutans Lindau Leaves by Gas Chromatography-Mass Spectrometry-Based Metabolomics and Molecular Docking Simulation
title_fullStr Characterization of α-Glucosidase Inhibitors from Clinacanthus nutans Lindau Leaves by Gas Chromatography-Mass Spectrometry-Based Metabolomics and Molecular Docking Simulation
title_full_unstemmed Characterization of α-Glucosidase Inhibitors from Clinacanthus nutans Lindau Leaves by Gas Chromatography-Mass Spectrometry-Based Metabolomics and Molecular Docking Simulation
title_short Characterization of α-Glucosidase Inhibitors from Clinacanthus nutans Lindau Leaves by Gas Chromatography-Mass Spectrometry-Based Metabolomics and Molecular Docking Simulation
title_sort characterization of α glucosidase inhibitors from clinacanthus nutans lindau leaves by gas chromatography mass spectrometry based metabolomics and molecular docking simulation
topic α-glucosidase inhibitors
Clinacanthus nutans
diabetes
GC-MS
partial least square
url http://www.mdpi.com/1420-3049/23/9/2402
work_keys_str_mv AT suganyamurugesu characterizationofaglucosidaseinhibitorsfromclinacanthusnutanslindauleavesbygaschromatographymassspectrometrybasedmetabolomicsandmoleculardockingsimulation
AT zalikhaibrahim characterizationofaglucosidaseinhibitorsfromclinacanthusnutanslindauleavesbygaschromatographymassspectrometrybasedmetabolomicsandmoleculardockingsimulation
AT qamaruddinahmed characterizationofaglucosidaseinhibitorsfromclinacanthusnutanslindauleavesbygaschromatographymassspectrometrybasedmetabolomicsandmoleculardockingsimulation
AT nikidrisnikyusoff characterizationofaglucosidaseinhibitorsfromclinacanthusnutanslindauleavesbygaschromatographymassspectrometrybasedmetabolomicsandmoleculardockingsimulation
AT bishafathamahuzir characterizationofaglucosidaseinhibitorsfromclinacanthusnutanslindauleavesbygaschromatographymassspectrometrybasedmetabolomicsandmoleculardockingsimulation
AT vikneswariperumal characterizationofaglucosidaseinhibitorsfromclinacanthusnutanslindauleavesbygaschromatographymassspectrometrybasedmetabolomicsandmoleculardockingsimulation
AT faridahabas characterizationofaglucosidaseinhibitorsfromclinacanthusnutanslindauleavesbygaschromatographymassspectrometrybasedmetabolomicsandmoleculardockingsimulation
AT khozirahsaari characterizationofaglucosidaseinhibitorsfromclinacanthusnutanslindauleavesbygaschromatographymassspectrometrybasedmetabolomicsandmoleculardockingsimulation
AT heshamelseedi characterizationofaglucosidaseinhibitorsfromclinacanthusnutanslindauleavesbygaschromatographymassspectrometrybasedmetabolomicsandmoleculardockingsimulation
AT alfikhatib characterizationofaglucosidaseinhibitorsfromclinacanthusnutanslindauleavesbygaschromatographymassspectrometrybasedmetabolomicsandmoleculardockingsimulation